The content on this site is intended for healthcare professionals only
Prof Gordon McVie provides highlights from ecancer for June 2016:
Events
ecancer's Future Horizons in Lung Cancer event
Video
Journal
A prognostic index for locoregional recurrence after neoadjuvant chemotherapy
Cancer-associated thrombotic microangiopathy
Targeted therapies and immunotherapy in non-small-cell lung cancer
Education
Advancements in paediatric Acute lymphoblastic leukemia management
ASCO 2024: Lung cancer highlights
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Multiple myeloma in a resource constrained setting
Relapsed refractory multiple myeloma
Amivantamab shows robust efficacy in post-platinum therapy patients with EGFR Ex20ins NSCLC
Four chemo cycles given with durvalumab and tremelimumab optimise response and tumour shrinkage in patients with mNSCLC
LUMINANCE: Results support use of durvalumab and platinum-etoposide for extensive stage SCLC
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer
